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ABSTRACT           68 
Background and Purpose: An ischemic stroke occurs when blood flow to an area of the brain is 69 
restricted and can cause numbness or weakness on one side of the body, facial droop, trouble speaking, 70 
and trouble walking. Patients who seek medical attention for symptoms within three hours of their onset 71 
can be eligible to receive tissue plasminogen activator (tPA).  These patients often have less resultant 72 
disability than their counterparts who did not receive the drug. The purpose of this case reports is to 73 
display the positive effects of tPA and physical rehabilitation following a stroke in the acute care setting. 74 
Case Description: The patient was an 83-year-old Caucasian female with an acute right thalamic 75 
stroke and complaints of left sided weakness with numbness and tingling. tPA was administered within 76 
one hour of symptom onset. Strength, sensation, coordination, and functional mobility were evaluated 77 
before and after the administration. 78 
 Outcomes: The patient in this case report showed improvements in strength (grossly 2-/5 to 4-/5), 79 
sensation (numbness to intact), and coordination (unable to perform to slowed and decreased accuracy) as 80 
a result of tPA administration following a stroke. The patient was discharged home with minor 81 
impairments in functional mobility. 82 
Discussion: This case report demonstrates the importance of early stroke symptom recognition so 83 
that eligible patients can receive tPA to decrease impairments and to have better outcomes in the area of 84 
functional mobility.  85 
Word count: 222 86 
 87 
BACKGROUND and PURPOSE  88 
An ischemic stroke occurs when blood flow to an area of the brain is restricted 1. Stroke 89 
is the fifth leading cause of death in the U.S. and kills 140,000 each year2. Symptoms of stroke 90 
include sudden numbness or weakness on one side of the body, facial droop, trouble speaking, 91 
and trouble walking. Patients who seek medical attention for symptoms within 3 hours of their 92 
onset can be eligible to receive tissue plasminogen activator (tPA).  With ischemic strokes, tPA 93 
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works by dissolving the blood clot to enhance blood flow in the brain which helps decreases the 94 
damage caused by the stroke. Patients who receive tPA within 3 hours often have less resultant 95 
disability than their counterparts who did not receive the drug3. 96 
Pharmacological and physical therapy interventions are important to reduce effects of 97 
stroke. Patients affected by stoke can display decreased strength, decreased balance, numbness 98 
and/or tingling, ataxia, flaccidity, spasticity, inattention or neglect, visual changes, and speech 99 
disturbances4. While tPA targets the area of the brain affected by the stroke to help decrease 100 
these impairments, physical therapy is important to help the patient regain their functional 101 
mobility and independence. The purpose of this case reports is to display the positive effects of 102 
tPA and physical rehabilitation following a stroke in the acute care setting. 103 
CASE DESCRIPTION 104 
 105 
Patient History 106 
The patient provided written consent to participate in this case report. The patient was an 83-107 
year-old Caucasian female suspected to have had a cerebrovascular accident (CVA). The patient 108 
presented to the emergency department with complaints of a stroke-like symptoms with sudden 109 
onset at 18:00 that day. The patient reported she was eating dinner with her husband when he 110 
noticed the patient had a left facial droop. The patient also experienced numbness and tingling in 111 
her left foot and reported her throat felt like it was closing. Upon emergency medical service 112 
(EMS) arrival, she had a severe left sided facial droop and her left side was completely flaccid. 113 
tPA was administrated at the hospital at 18:50. Magnetic resonance imaging (MRI) carried out 114 
24 hours after the administration of tPA confirmed an acute right thalamic CVA. See Figure 1 115 
for MRI.  116 
The patient’s past medical history included hypertension and lipidemia, which she was 117 
controlling with medications. See Appendix 1 for full list of medications. No significant or 118 
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relevant surgical history was deemed to interfere with tPA or physical therapy intervention. The 119 
patient stated that she would like to return to her prior level of function (PLOF) with the help of 120 
physical therapy. 121 
Systems Review 122 
A systems review was performed in the emergency department before and after tPA was 123 
administered. Overall, all systems were impaired before and after tPA administration; but 124 
improvements in the musculoskeletal and neuromuscular systems were evident after the tPA was 125 
administered. See Table 1 for systems reviews. 126 
Clinical Impression  127 
 128 
The patient’s primary complaint was left sided weakness with numbness and tingling. 129 
The differential diagnoses, before the MRI confirmation, included cardioembolic stroke, small 130 
vessel disease/lacune, thromboembolic, hypercoagulable state-related infarct, and transient 131 
ischemic attack. Physical therapy was determined necessary to address impairments in areas such 132 
as strength, sensation, coordination, and gait. The patient was a good candidate for this case 133 
report as she was motivated to return to her PLOF and was compliant with all medical and 134 
therapy inventions. 135 
Examination – Tests and Measures 136 
 The patient was agreeable to a physical therapy examination that included strength, 137 
sensation, coordination, and functional mobility assessment. Manual Muscle Testing (MMT) of 138 
myotomes C5-C8, L2-L4, and S1-S2 was performed with patient sitting at the edge of the bed 139 
and graded by the system adopted by Kendall5. Light touch of dermatomes L2-L5 and S1 was 140 
assessed. Coordination of upper and lower extremities was tested using rapid alternating 141 
movements (RAMs), finger to nose test with increasing speed and eyes closed, and heel to shin 142 
test. Bed mobility, transfers, and ambulation were also assessed during the initial examination6. 143 
Refer to Table 2 for findings. 144 
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Outcome Measures 145 
A variety of outcome measures were used to assess the patient’s progress over the course 146 
of the hospital stay. The National Institution of Health (NIH) Stroke Scale is used with patients 147 
that have suffered an acute ischemic stroke, hemorrhagic stroke, or transient ischemic attack. It 148 
assesses acute status, treatment efficacy, and helps predict outcomes. It is only used when the 149 
patient is initially assessed. The scale has a high reliability and validity when used by providers 150 
who use the scale on a daily basis7. The patient scored a 6 on the NIH scale at admission, which 151 
is indicative of a mild stroke.  152 
The Modified Rankin Handicap Scale compares the patient’s functional independence 153 
after suffering a stroke to his/her pre-stroke function. Scores are determined based on how the 154 
patient performs activities of daily living (ADLs), their neurological deficits, and other aspects of 155 
their life. For the stroke population it has an excellent test-retest reliability and inter-rated and 156 
intra-rated reliability8. The patient was determined to score a 0 (no symptoms or disability) 157 
before admission, and a 1 (no significant disability despite symptoms) at discharge. 158 
The Activity Measure for Post-Acute Care (AM-PAC) "6-Clicks" Inpatient Short Forms 159 
uses 6 questions to assess functional outcomes of patients in post-acute care settings. It measures 160 
difficulty, assistance, and limitations in mobility and/or ADLs. It also helps predict discharge. It 161 
has a high test-retest reliability and interrater reliability between medical professionals. There is 162 
no validity reported for this outcome measure. The patient received 3’s in all parts of the 163 
mobility domain at both evaluation and discharge, which suggested that the patient would need 164 
“a little” help with the mobility activities and had a 40.47% decrease in function 9. Refer to Table 165 
3 for results and interpretation of all outcome measures for this patient. 166 
Clinical Impression: Evaluation, Diagnosis, Prognosis 167 
The patient presented to the emergency department with left facial droop, left side 168 
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weakness, and left lower extremity numbness. The patient and spouse were able to identify 169 
symptoms immediately and sought medical attention. The medical team was able to administer 170 
tPA within one hour of symptom onset. An MRI confirmed that the patient experienced an acute 171 
right thalamic stroke. The patient was agreeable to further medical treatment and physical 172 
therapy interventions. At the time of physical therapy evaluation, the patient presented with left 173 
side weakness, impaired coordination of the left upper and lower extremities, and gait 174 
abnormalities; but the symptoms had improved from the initial evaluation in the emergency 175 
room. The patient also agreed that she already noticed improvement of symptoms since tPA 176 
administration.  177 
The medical diagnosis was determined to be cerebral infarction (I63.9). The physical 178 
therapy diagnoses included hemiparesis (I69.354) and ataxia following cerebral infarction 179 
(I69.393). The patient had a good prognosis with physical therapy. The patient was able to 180 
receive tPA within the most effective window10, and prior to tPA, she had been exercising 3 days 181 
a week, had a supportive spouse and family, and she was motivated to return to her prior level of 182 
function11. The patient also had an initial NIH Stroke Scale score of 6 before tPA and her 183 
symptoms improved after. A NIH score of <5 is a strong predictor of being discharged home12.  184 
Occupational therapy and speech therapy were also consulted as part of the stroke team. 185 
Patient was scheduled for a right carotid endarterectomy (CEA) three days after physical therapy 186 
evaluation. See Figure 2 for a description of the surgery. The patient received a physical therapy 187 
treatment by a physical therapy assistant before the surgery to prevent deconditioning. A 188 
physical therapy re-evaluation was ordered and performed 1-day post-operation to determine 189 
further needs for the patient once discharged. After the re-evaluation, it was recommended that 190 
the patient receive home health physical therapy (HHPT) to improve strength, balance, 191 
coordination, and mobility. Short-term goals for the patient were developed. Refer to Table 4 for 192 
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specific goals. 193 
Intervention and Plan of Care  194 
Before performing the initial evaluation with the patient, the student physical therapist 195 
(SPT) performed a record review. The SPT consulted the patient’s nurse to receive any other 196 
updates in the patient’s care and status. An evaluation that involved a patient history, assessed 197 
strength, sensation, coordination, bed mobility, transfers, and gait was carried out. After the 198 
evaluation, important information about the patient’s performance and further recommendations 199 
for therapy were relayed to the nurse. All information gathered by the SPT was recorded in the 200 
electric medical record system, EPIC. The patient was also evaluated by occupational and speech 201 
therapy, but therapy was not indicated. The patient was informed by the medical team that she 202 
was eligible for a right CEA to remove plaque in the carotid artery to decrease her risk of future 203 
stroke. The patient was agreeable to surgery and participated in a physical therapy treatment 204 
session with a physical therapy assistant (PTA) to prevent deconditioning and learn new 205 
movement strategies prior to surgery. The session with the PTA focused on functional mobility. 206 
During that session the PTA had the hospital bed mimic the patient’s bed at home (i.e. head of 207 
bed flat, height of bed, railings down) and gave instruction for rolling, performing supine to sit, 208 
and sit to supine. The PTA gave verbal cues and broke the task down into parts as needed. The 209 
patient was educated on momentum strategies and limb and trunk positioning to make bed 210 
mobility the most effective. The patient also practiced transfers from surfaces that most closely 211 
mimic the patient’s home environment (i.e. height of bed, height of chair, height of toilet). The 212 
PTA educated the patient on “nose over toes” and pushing up with arms from the surface instead 213 
of on other objects in the room. Again, the PTA gave verbal cues and broke the task down into 214 
parts as needed. To end the session the patient ambulated in the halls. The PTA gave feedback 215 
for heel strike, arm swing, and posture and recorded the distance ambulated. The patient did not 216 
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require an assistive device during the treatment session. A physical therapy re-evaluation was 217 
performed after the surgery to determine if there were any further impairments that required 218 
discharge recommendations. Refer to Table 5 for specific interventions. 219 
Timeline 220 
 221 
 222 
 223 
 Outcomes 224 
The patient in this case report showed improvements in strength, sensation, and 225 
coordination as a result of tPA administration following a stroke. The patient was discharged 226 
home with HHPT and minor impairments in functional mobility. Follow-up in the neurologist’s 227 
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office was scheduled. It is likely that her good outcomes following her stroke were because she 228 
was able to recognize the symptoms at onset, sought appropriate medical attention, did not 229 
smoke, exercised regularly, and participated in all physical therapy and medical interventions.  230 
Refer to Table 6 for detailed outcomes.  231 
Discussion  232 
 This case report displayed how tPA decreased the impairments experienced by this 233 
patient after the onset of a stroke. Table 2 which compares the systems review both before and 234 
after tPA was administered. The improvements seen at that time were maintained throughout the 235 
patient’s hospital and stay a CEA procedure. The patient was able to be discharged home and 236 
receive HHPT. 237 
The effects observed in this case are consistent with the literature that states that tPA 238 
received within 3 hours of symptom onset reduces impairments. Additionally, this patient had 239 
several positive prognostic indicators. These factors yield a good prognosis after stroke, so it is 240 
difficult to determine whether her positive outcome was solely impacted by the tPA, and thus 241 
limiting the generalizability of this study. Perhaps this patient would have regained most of her 242 
function without receiving the prompt medical attention that she did. Future case reports 243 
including patients with poor prognostic factors may enhance the literature that supports the use 244 
of tPA.  245 
The strengths of this case included the thorough documentation and prompt medical 246 
attention provided by all members of this patient’s healthcare team. The testing and re-testing of 247 
systems and function were performed in a timely manner so that outcomes were accurate. In 248 
conclusion, this case report demonstrates the importance of early stroke symptom recognition in 249 
order to receive tPA to decrease functional impairments and to have better outcomes with 250 
physical therapy.  251 
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 TABLES and FIGURE 298 
Table 1 Systems Review in Emergency Department 299 
System Before tPA After tPA 
Cardiovascular/Pulmonary  CTA scan of neck: 
70% diameter reduction of the right 
carotid artery  
50% diameter reduction of the left 
carotid artery 
Unchanged 
Musculoskeletal Left UE Strength: Grossly 2+/5  
Left LE Strength: Grossly 3/5 
Left UE Strength: Grossly 4-/5  
Left LE Strength: Grossly 4-/5 
Neuromuscular Left facial droop 
 
Finger-to-nose: 
Intact on right 
Unable to perform on left 
 
 
Numbness/tingling in left lower 
extremity 
Facial droop absent 
 
Finger-to-nose:  
Intact on right 
Slow and decreased accuracy 
on left 
 
Light touch: intact throughout  
Integumentary Clammy and diaphoretic Intact  
Communication Slight slurred speech Intact 
Affect, Cognition, 
Language, Learning Style 
Alert and orientated to person, 
place, and time  
Alert and oriented to person, 
place, time, situation 
*CTA= Computed tomography angiography 300 
* UE= Upper Extremity 301 
* LE= Lower Extremity 302 
 303 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
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Table 2 Tests and Measures during Initial Evaluation 311 
Tests & Measures Initial Evaluation Results 
Manual Muscle 
Testing 
Right UE Grossly 5/5 
Right LE Grossly 5/5 
Left UE Grossly 4-/5  
Left LE Grossly 4-/5  
Sensation  Light touch intact throughout but hypersensitivity left lateral thigh 
Coordination RAMs: 
Intact on right upper and lower extremities 
Decreased speed and slight delay on left UE and LE 
 
Finger-to-nose: 
Intact on right 
Slow and decreased accuracy on left 
 
Heel-to-shin: 
Intact on right 
Slow and decreased accuracy on left 
Bed Mobility The patient required supervision for rolling, supine to sit, sit to 
supine, and scooting activities with HOB elevated and use of 
handrails  
Transfers The patient required minimal assistance to perform transfers from 
bed to chair and chair to bed. 
Gait analysis The patient required minimal assistance on the right side with a 
hand-held assist for ambulation. The patient was able to walk 450 
feet with a 30 second standing rest break due to fatigue. The patient 
demonstrated a flat foot on the left, slight genu recurvatum on the 
left when fatigued, and scissoring gait during dual tasks. 
*UE= Upper Extremity  312 
*LE= Lower Extremity 313 
*RAMS= Rapid Alternating Movements 314 
* HOB= Head of Bed 315 
 316 
 317 
 318 
 319 
 320 
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Table 3 Outcome Measures 321 
Outcome Measures Results 
NIH Stroke Scale 
Before tPA 
NIH Stroke Scale  
Level of Consciousness (LOC) = 0 
LOC Question = 0                   
LOC Commands = 0 
Best Gaze = 0 
Visual = 0 
Facial Palsy = 0 
Motor Arm - Left = 1 
Motor Arm - Right = 0 
Motor Leg - Left = 1                  
Motor Leg - Right = 0                  
Limb Ataxia = 2                       
Sensory = 2                                 
Best Language = 0                    
Dysarthria = 0                        
Extinction and Inattention = 0     
  
NIH Stroke Scale Score = 6 (mild stroke) 
Modified Rankin 
Scale  
 
 
 
 
 
 
 
 
 
 
 
0 No symptoms at all: Before Admission 
1 No significant disability despite symptoms; able to carry out all 
usual duties and activities: At Discharge 
2 Slight disability; unable to carry out all previous activities, but able 
to look after own affairs without assistance  
3 Moderate disability; requiring some help, but able to walk without 
assistance  
4 Moderately severe disability; unable to walk without assistance 
and unable to attend to own bodily needs without assistance  
5 Severe disability; bedridden, incontinent and requiring constant 
nursing care and attention  
6 Dead 
AM-PAC “6 clicks” 
Basic Mobility 
Domain 
 
 
 
 
 
 
 
 
At evaluation and discharge: 
Bed mobility- 3 
Sit to stand; stand to sit- 3 
Supine to sit- 3 
Seated transfers- 3 
Ambulation- 3 
Ascending stairs- 3 
 
40.47% decrease in function 
 
Scoring related to difficulty: 
1 = Total; dependent 
2 = A lot; maximum or moderate 
assistance 
3 = A little; minimum assistance, 
contact guard assistance, 
supervision 
4 = None; no human assistance 
needed 
 
 322 
 323 
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Table 4 Goals  324 
Short Term Goals 
1. Patient will perform all bed mobility safely, independently, and with no assistance or cueing. 
2. Patient will perform all transfers with supervision and no assistive device 
3. Patient will ambulate 500 ft with supervision and no assistive device with stable vital signs. 
Table 5 Interventions 325 
 Evaluation (after tPA) Rx Re-evaluation (after CEA) 
Bed mobility 
Purpose: 
functional mobility  
Assessed how the patient 
rolled, performed supine 
to sitting, sitting to 
supine, and scooting. 
 
Log rolling to left and 
right x5 each 
 
Supine < > sit x5 
 
Sit < > supine x5 
Assessed how the patient 
rolled, performed supine to 
sitting, sitting to supine, and 
scooting. Compared 
changes, if any, from initial 
evaluation. 
Manual Muscle 
Testing 
Purpose: track 
progress 
Myotomes C5-C8 and 
L2-L4 and S1-S2 
N/A Myotomes C5-C8 and L2-
L4 and S1-S2.  
Compared changes, if any, 
from initial evaluation. 
Sensation 
Purpose: track 
progress 
Light touch L2-L5 and 
S1 
N/A Light touch of L2-L5 and 
S1. Compared changes, if 
any, from initial evaluation. 
Coordination 
Purpose: track 
progress 
Finger-to-nose test, heel-
to-shin test, rapid 
alternating movements of 
upper and lower 
extremities. 
N/A Finger-to-nose test, heel-to-
shin test, rapid alternating 
movements of upper and 
lower extremities. Compared 
changes, if any, from initial 
evaluation. 
Transfers 
Purpose: 
functional mobility 
Transfers to and from 
bed, chair, and toilet.  
Sit < > stand bed x5 
 
Sit< > stand chair x5 
 
Sit < > stand toilet x5 
Transfers to and from bed, 
chair, and toilet. Compared 
changes, if any, from initial 
evaluation. 
Gait 
Purpose: 
functional mobility 
Assessed gait pattern of 
patient. Recorded the 
distance ambulated by the 
patients and any 
impairments of gait. 
Ambulated in halls 
500 feet with focus on 
quality of gait 
 
 
 
Assessed gait pattern of 
patient. Recorded the 
distance ambulated by the 
patients and any 
impairments of gait. 
Compared changes, if any, 
from initial evaluation. 
Leboeuf, Tissue Plasminogen Activator Effects on Stroke and Physical Therapy Outcomes in Acute Care: A Case 
Report 
 
16 
 
Vital Signs 
Purpose: ensure pt 
is responding well 
to therapy 
Assessed heart, oxygen 
saturation, and blood 
pressure of patient as 
patient became 
symptomatic and at end 
of session and reported to 
nurse. 
Assessed heart, 
oxygen saturation, and 
blood pressure of 
patient as patient 
becames symptomatic 
and at end of session 
and reported to nurse. 
Assessed heart, oxygen 
saturation, and blood 
pressure of patient as patient 
became symptomatic and at 
end of session and reported 
to nurse. 
 326 
Table 6 327 
Outcomes Before tPA  At Discharge 
Strength Left UE Strength: Grossly 
2+/5  
Left LE Strength: Grossly 
3/5 
Left UE Strength: Grossly 4-/5 
Left LE Strength: Grossly 4-/5 
Sensation Numbness/tingling in left 
lower extremity 
Light touch intact 
throughout but 
hypersensitivity left lateral 
thigh 
Coordination Failed finger-to-nose test 
on left 
Slow and decreased 
accuracy with finger-to-
nose test on left 
Bed mobility Not tested-was independent 
before admission 
Supervision 
Transfers Not tested- was 
independent before 
admission 
Supervision 
Gait Not tested- was 
independent before 
admission 
Minimum Assistance 
Modified Rankin Scale Not tested- 0 (no 
symptoms) before 
admission 
 
1-No significant disability 
despite symptoms; able to 
carry out all usual duties 
and activities 
AM-PAC Not tested- was 
independent before 
admission 
40.47% decrease in function 
 328 
 329 
 330 
 331 
 332 
 333 
 334 
 335 
 336 
 337 
 338 
 339 
 340 
 341 
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Figure 1 MRI 342 
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 344 
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Figure 2 CEA description 346 
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Appendix 1 Home Medications 357 
  
Home Medications Indications 
Gemfibrozil (LOPID) High Cholesterol 
Atenolol (TENORMIN) High Blood Pressure 
Ezetimibe (ZETIA) High Cholesterol 
Venlafaxine XR (EFFEXOR-XR) Nerve pain or antidepressant 
ASCORBIC ACID Low Vitamin C 
CHOLECALCIFEROL Low Vitamin D 
Sulfamethoxazole-trimethoprim 
(BACTRIM DS, SEPTRA DS) 
Treat/prevent infections 
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CARE Checklist 377 
CARE Content Area Page 
1. Title – The area of focus and “case report” should appear in the title 2 
2. Key Words – Two to five key words that identify topics in this case report 2 
3. Abstract – (structure or unstructured) 
a. Introduction – What is unique and why is it important? 
b. The patient’s main concerns and important clinical findings. 
c. The main diagnoses, interventions, and outcomes. 
d. Conclusion—What are one or more “take-away” lessons? 
3 
4. Introduction – Briefly summarize why this case is unique with medical literature 
references. 
3-4 
5. Patient Information 
a. De-identified demographic and other patient information. 
b. Main concerns and symptoms of the patient. 
c. Medical, family, and psychosocial history including genetic information. 
d. Relevant past interventions and their outcomes. 
4-5, 18 
6. Clinical Findings – Relevant physical examination (PE) and other clinical findings 5-7,  
12-14 
7. Timeline – Relevant data from this episode of care organized as a timeline (figure 
or table). 
9 
8. Diagnostic Assessment 
a. Diagnostic methods (PE, laboratory testing, imaging, surveys). 
b. Diagnostic challenges. 
c. Diagnostic reasoning including differential diagnosis. 
d. Prognostic characteristics when applicable. 
7,17 
9. Therapeutic Intervention 
a. Types of intervention (pharmacologic, surgical, preventive). 
b. Administration of intervention (dosage, strength, duration). 
c. Changes in the interventions with explanations. 
8-9 
15-16 
10. Follow-up and Outcomes 
a. Clinician and patient-assessed outcomes when appropriate. 
b. Important follow-up diagnostic and other test results. 
c. Intervention adherence and tolerability (how was this assessed)? 
d. Adverse and unanticipated events. 
9-10 
16 
11. Discussion 
a. Strengths and limitations in your approach to this case. 
b. Discussion of the relevant medical literature. 
c. The rationale for your conclusions. 
d. The primary “take-away” lessons from this case report. 
10 
12. Patient Perspective – The patient can share their perspective on their case. N/A 
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     379 
13. Informed Consent – The patient should give informed consent. 2 
